J F Robertson|C C Cummings

Showing results (101-110 of 189) with videos related to

Pageof 19

Sort By:

Breast Cancer Research and Treatment|January 1, 1994

Biological factors of prognostic significance in locally advanced breast cancerJ F Robertson, I O Ellis, D Pearson, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Prospective assessment of the role of five tumour markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.

European Journal of Cancer (Oxford, England : 1990)|October 26, 1999

The prognosis of small primary breast cancersJ Kollias, C A Murphy, C W Elston, et al.

The British Journal of Surgery|June 1, 1988

Effect of LHRH agonist, Zoladex, on ovarian histologyK Williamson, J F Robertson, I O Ellis, et al.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992

Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancerN P Sacks, J F Robertson, I O Ellis, et al.

The Australian and New Zealand Journal of Surgery|September 1, 1996

Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytologyG H Poole, P C Willsher, S E Pinder, et al.

The Journal of Pathology|October 1, 1989

An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinomaA Hitchcock, I O Ellis, J F Robertson, et al.

Advances in Anatomic Pathology|October 8, 2005

Clinical value of epidermal growth factor receptor expression in primary breast cancerR S Rampaul, S E Pinder, R I Nicholson, et al.

Breast Cancer Research and Treatment|January 1, 1992

Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapyJ F Robertson, A R Dixon, R I Nicholson, et al.

European Journal of Cancer (Oxford, England : 1990)|November 27, 2001

Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapyS M Tan, K L Cheung, P C Willsher, et al.

Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:

Pageof 19

Breast Cancer Research and Treatment|January 1, 1994

Biological factors of prognostic significance in locally advanced breast cancerJ F Robertson, I O Ellis, D Pearson, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Prospective assessment of the role of five tumour markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.

European Journal of Cancer (Oxford, England : 1990)|October 26, 1999

The prognosis of small primary breast cancersJ Kollias, C A Murphy, C W Elston, et al.

The British Journal of Surgery|June 1, 1988

Effect of LHRH agonist, Zoladex, on ovarian histologyK Williamson, J F Robertson, I O Ellis, et al.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992

Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancerN P Sacks, J F Robertson, I O Ellis, et al.

The Australian and New Zealand Journal of Surgery|September 1, 1996

Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytologyG H Poole, P C Willsher, S E Pinder, et al.

The Journal of Pathology|October 1, 1989

An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinomaA Hitchcock, I O Ellis, J F Robertson, et al.

Advances in Anatomic Pathology|October 8, 2005

Clinical value of epidermal growth factor receptor expression in primary breast cancerR S Rampaul, S E Pinder, R I Nicholson, et al.

Breast Cancer Research and Treatment|January 1, 1992

Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapyJ F Robertson, A R Dixon, R I Nicholson, et al.

European Journal of Cancer (Oxford, England : 1990)|November 27, 2001

Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapyS M Tan, K L Cheung, P C Willsher, et al.

Pageof 19